News & Highlights

ICYMI: Business Insider: “Big Pharma’s Big Tax Dodge”

Aug 9, 2023

International Experts Slam Big Pharma’s Egregious Offshoring Scam of U.S. Read More

ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS

Jun 2, 2023

Physicians Highlight How Big Pharma Games the System to Boost Profits and Read More

ICYMI: LAWMAKERS MAKE BIPARTISAN CALL FOR FURTHER ACTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS

Mar 28, 2023

Members of Congress Send Letter Encouraging USPTO to Close Loopholes Exploited Read More

ICYMI: I-MAK: Cracking Down on Big Pharma’s Patent Abuse to Lower Drug Prices Should Be Bipartisan Priority

Jan 27, 2023

Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress Read More

ICYMI: WHAT COMES NEXT AFTER MAJOR STEP FORWARD ON DRUG PRICING

Sep 19, 2022

What Comes Next After Major Step Forward on Drug Pricing Real Clear Health Read More

ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT

Aug 8, 2022

Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower Read More

ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS

Aug 3, 2022

Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can Read More

ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Jul 19, 2022

Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug Read More

ICYMI: CBO FINDS HOLDING BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE TACTICS WOULD SAVE BILLIONS OF DOLLARS

Jun 8, 2022

Scoring Shows Solutions to Crack Down on Branded Drug Companies’ Read More

ICYMI: ANALYSIS REVEALS IMPACT OF BIG PHARMA’S ANTI-COMPETITIVE PRACTICES AROUND INHALERS

May 18, 2022

Brand Name Drug Companies Prevent Competition from More Affordable Read More